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Summary 
 
The role of bacterial diversity is not completely understood. Several factors can shape this 
diversity, either within a host or in an external environment. It is important to understand this 
process and its driving forces both in ecological and evolutionary terms.  In this thesis, we study 
bacterial adaptation to the mammalian gut, which is one of the most complex bacterial 
environments. The mammalian gut is also thought to be variable over time. To thrive in an 
environment such as this, the accumulation of adaptive mutations is essential. In populations 
where several beneficial mutations segregate simultaneously, many small effect mutations are 
lost due to competition with the ones of larger effect, a process known as clonal interference 
(CI). 
As an adaptive walk is expected to involve more than one adaptive step, we have studied 
the adaptive mutation corresponding to the first and second steps of adaptation of Escherichia 
coli to the mouse gut. We observed an intense process of clonal interference occurring during 
the first colonization that seems to decrease in the second colonization. This analysis showed 
that the rate of adaptation of E.coli to the mouse gut seems to be declining as the population 
adapts. Despite the smaller effect of interference in the second colonization, the comparison of 
the genetic basis of adaptation from both colonizations revealed a remarkable parallelism 
(mainly IS driven) in the adaptation of E.coli to the mouse gut which continues to adapt in a 
second colonization to the gut. 
We further tested the effect of these mutations in the expression of their respective genes 
and in the mutant’s fitness when exposed to different carbon sources.  The results indicate that 
oxygen level and the metabolic pressures are important stimulus in the adaptation to the studied 
environment.  
In sum, though the gut is a highly complex environment, the repeatability of evolution shows 
that parallel evolution is not restricted to the laboratory environments and may be very common 
in nature.  
 
Contributions to this work: I performed all the work presented in this thesis, except the work presented 
in Figure 4, Figure 5 (results from first colonization), Figure 6 (sequencing analysis of the clones) and 
Figure S1. 
Some of the results here presented are already accessible in the PLoS Genetics paper “João Barroso-
Batista, Ana Sousa, Marta Lourenço, Marie-Louise Bergman,  Daniel Sobral,  Jocelyne Demengeot, 
Karina B. Xavier, Isabel Gordo. The first steps of adaptation of Escherichia coli to the gut are dominated by 
soft sweeps. PLoS Genet. 2014 Mar;10(3):e1004182.”. 
This paper was mentioned by Carl Zimmer on an article about "evolutionary forecasting” 
(http://www.simonsfoundation.org/quanta/20140717-the-new-science-of-evolutionary-forecasting/).  
 
Keywords: Escherichia coli; Parallel adaptation; Natural environment; Microbiota; 
Generalists; Molecular Evolution; Insertion Sequences (IS); Gene expression studies 
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Sumário 
 
Existe ainda algum desconhecimento sobre o papel da diversidade bacteriana. São muitos 
os factores que a podem modular, quer num hospedeiro quer num ambiente externo. É 
importante perceber este processo e as suas forças motrizes tanto em termos evolutivos como 
ecológicos. 
Nesta tese abordamos o estudo da adaptação bacteriana ao intestino dos mamiferos, um 
dos ambientes bacterianos mais complexos. Julga-se que o ambiente dentro do intestino seja 
muito variável devido a vários factores como os niveis de oxigénio (flutuantes), os nutrientes 
ingeridos pelo hospedeiro, o pH, o uso de antibióticos e o sistema imunitário. Para prosperar 
em ambientes como este, a acumulação de mutações benéficas é essencial. Em populações 
em que diversas mutações benéficas surgem em simultâneo, as de menor perder-se-ão devido 
á competição com as de maior efeito que se irão fixar. Se esta mutações forem de impacto 
semelhante será dificil a fixação de uma delas devido a intensa competição entre elas. A este 
processo dá-se o nome de interferência clonal.  
O organismo modelo que usámos durante este estudo foi a Escherichia coli MG1655. É uma 
bacteria anaeróbia facultativa, gram-negativa e com crescimento óptimo à temperatura de 
37ºC. É um dos organismos modelos mais bem estudados que para além do crescimento 
rápido em condições laboratoriais, tem uma base genética bem estabelecida e uma sequência 
genómica determinada.  
Embora a E.coli represente menos de 1% das bactérias presentes no intestino humano (1), 
está descrita como sendo uma das primeiras a colonizar recém-nascidos (primeiras 40 horas 
após o parto) e ainda recentemente foi descrita como sendo a bactéria mais abundante na 
placenta humana (2)(3).  
Alem do mais a E.coli sendo uma bacteria comensal tem a capacidade de se tornar 
patogénica. Assim torna-se a candidata ideal para estudos de transição nas interacções 
bacteria-hospedeiro podendo variar entre mutualismo, comensalismo ou até patogenese 
oportunista (4). 
Nesta tese procedemos à análise da base genética da adaptação da E.coli MG1655 durante 
duas colonizações consecutivas do intestino do ratinho. Para isso foi introduzida por “gavage” 
(que consiste na introdução directa de bactérias no estômago do ratinho por via de um tubo) 
uma co-cultura de duas estirpes geneticamente iguais com a excepção da fluorescência 
codificada no seu genoma (5). Como ancestral da segunda colonização foi usado um dos 
clones isolados das populações evoluidas durante a primeira colonização. A base genética dos 
clones evoluídos nestas duas colonizações foi descrita com base em dados de sequenciação 
do genoma completo (WGS – whole genome sequencing). 
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A análise genética dos clones mostrou um grande paralelismo entre as mutações adaptativas 
que surgiram na primeira e segunda colonizações. O primeiro passo adaptativo correspondeu à 
inactivação do operão gat ( responsável pelo metabolismo do galactitol). O segundo passo 
caracterizou-se pela a inserção de uma sequência de inserção (IS) nas regiões regulatórias de 
quatro genes o dcuB, focA, arcA e o yjjP, pela inserção de um IS na região codificante dos 
genes radA e oppB e ainda por uma mutação pontual (ou pequenas deleções ou inserções) no 
gene srlR. Sendo alguns destes genes de elevada importância para a bactéria (por exemplo o 
gene arcA é um dos reguladores mais importantes na passagem de respiração aeróbia para 
anaeróbia) questionou-se qual seria o papel dos elementos IS na região regulatória destes 
genes. Estes IS poderiam inactivar o gene, aumentar ou diminuir a sua expressão. Para 
investigar esta questão medimos o efeito da presença dos elementos IS na expressão dos 
respectivos genes. Algumas demonstraram possuir um efeito significativo na expressão dos 
genes, sendo este dependente da presença de oxigénio no meio de cultura, apoiando a 
possibilidade de os niveis de oxigénio serem uma das pressões selectivas mais importantes 
dentro do intestino. O efeito destas mutações revelou ainda que os elementos IS têm um papel 
fundamental neste processo adaptativo a que a E.coli está a ser sujeita.  
Para além dos genes alvo de inserções medimos ainda a expressão do gene srlA, uma vez 
que este gene faz parte do operão responsável pelo metabolismo do sorbitol estando sob 
controlo directo do repressor srlR (um dos genes mais atingido durante as duas colonizações). 
Verificámos que o gene srlA teve um aumento de expressão tanto em aerobiose como em 
anaerobiose demostrando assim que o sorbitol é provavelmente uma fonte de carbono 
importante para a E.coli no intestino. 
 
Para melhor perceber as dinâmicas desta adaptação da E.coli ao intestino do ratinho 
determinámos ainda a diversidade de haplótipos ao longo do período adaptativo de algumas 
das populações das duas colonizações. A análise desta diversidade revelou um regime de 
interferência clonal em ambas as colonizações (mostrando um dinâmica de “soft sweeps” que 
consiste no aparecimento de várias mutações ao mesmo tempo competindo entre elas mas 
nunca conseguindo a fixação na população). Esta interferência aparenta ser inferior na 
segunda colonização pois o número de haplótipos com mais de uma mutação a surgirem 
durante a primeira colonização é muito superior aos número dos da segunda colonização. Este 
estudo revelou ainda a presença de uma população com uma dinâmica adaptativa diferente em 
que uma das mutações do segundo passo de adaptação se fixou (evidenciando uma dinâmica 
de “hard sweep” que consiste no aparecimento de uma mutação benéfica que se fixa na 
população). Estas observações levam à conclusão de que a adaptação parece estar a diminuir 
apresentando ainda dinâmicas de adaptação diferentes das representadas na primeira 
colonização. 
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Para além disso estudámos ainda as potenciais pressões metabólicas presenciadas pela 
E.coli no interior do intestino. Para isso realizámos competições in vitro na presença de um 
conjunto de diferentes fontes de carbono a baixas e altas concentrações no meio de cultura. As 
fontes de carbono usadas foram o gluconato, o glucuronato, a manose e a ribose descritos 
como importantes para a E.coli quando dentro do intestino. O sorbitol foi tambem utilizado pois 
o seu metabolismo é um dos alvos de mutação. Os resultados destes ensaios suportam a 
hipótese da E.coli no intestino do ratinho estar a evoluir para o consumo de várias fontes de 
carbono em simultâneo e em baixas concentrações, por outras palavras estes clones estão a 
evoluir para serem generalistas num ambiente pobre em nutrientes. 
 
Os resultados aqui apresentados demonstram um grande paralelismo na adaptação da 
E.coli ao intestino do ratinho.  A reprodutibilidade da evolução da E.coli no ambiente complexo 
do intestino mostra que a evolução paralela não está restrita aos ambientes de laboratório mas 
também pode ser comum em ambientes naturais. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Palavras-Chave: Escherichia coli; Adaptation paralela; Ambiente natural; Microbiota; 
Generalistas; Evolução molecular; Sequências de Inserção; Estudos de expressão 
génica. 
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Introduction 
1. Mammalian gut and its inhabitants  
 
The mammalian (with emphasis in human) gut microbiota has become a subject of extensive 
research in recent years and the knowledge of the resident species and their potential functional 
capacity is rapidly growing.  
The human gut has being described as harboring an estimated 10
14 
cells of different species 
of bacteria and archaea establishing a highly diverse microbial ecosystem(6). This ecosystem is 
named microbiota and in association with the host has been described as a superorganism. 
Here  the microbiota acts as a virtual organ that provides multiple services to the body(7,8).  
The microbiota beyond being huge in numbers, harbors a vast genetic potential estimated to 
account for roughly 100 times the number of genes present in the human genome (9,10). 
The microbiota colonizes not only the gut but virtually every surface of the human body that 
is exposed to the external environment. Microbes flourish on our skin and in the genitourinary, 
gastrointestinal, and respiratory tracts(Fig1) (11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 –Microbial community composition at different body locations in a healthy human adapted from 
Spor et al in (11). The relative abundances of the six dominant bacterial phyla in each of the different body 
sites: the external auditory canal, the hair on the head , the mouth, the esophagus, the gastrointestinal tract, 
the vagina, the penis, the skin and the nostril. 
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By far the most heavily colonized organ is the gastrointestinal tract (GIT). The colon alone is 
estimated to contain over 70% of all the microbes in the human body (6,12), since the gut is rich 
in molecules that can be used as nutrients by microbes, making it a preferred site for 
colonization. The composition of this microbiota has been address by several studies. One 
example is Arumugam et al (13) that have characterized the phylogenetic variation across 
several human microbiomes at the phylum and genus level as is demonstrated in Figure 2. 
They showed that the Firmicutes and Bacteroidetes phyla constitute the vast majority of the 
dominant human gut microbiota. At the genus level they showed that the dominant were 
Bacteroides, Faecalibacterium and Bifidobacterium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The understanding of the complexity of intestinal communities as well as their genetic and 
metabolic potential is revealed of great importance. In the context of this community diversity 
means balanced and good microbiota (14). 
 
2. Escherichia coli in its natural environment: the mammalian gut 
 
The model organism used in this thesis is Escherichia coli which was discovered in the late 
1800’s by Theodor Escherich, a pediatric physician chasing the cause of the fatal intestinal 
diseases in children. It was first isolated from children fecal samples (15). 
 
Figure 2 – Phylogenetic profiles of human gut microbiome adapted from Arumugam M. et al in (13). Genera 
are colored by their respective phylum (see inset for color key). 
Inset: phylum abundance box plot. Unclassified genera under a higher rank are marked by asterisks. 
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Bacteria can live in many different environments and this diversity may be due to 
independent ecological specializations. E. coli is a species that can inhabit a variety of 
environments, being one of the predominant facultative anaerobes of the intestinal tract but also 
capable of occupying other secondary habitats (16) E.coli can colonize a variety of hosts with 
distinct body size, diets, morphologies or microbiota, being present in more than 90% of 
humans(17), 56% of wild animals, 23% in birds and 10% in reptiles (18). Despite being present 
in approximately 90% of the individuals of our species, the frequency of facultative anaerobes 
including E.coli present in the human microbiota is less than 1% in healthy individuals (1). 
 
E. coli usually colonizes the gastrointestinal tract of newborns in the first 40 hours after the 
birth, though the colonization mode is influenced by the mode of delivery, infant diet, hygiene 
levels and medication (2,19). Moreover recently it has been found to be the most abundant 
species in the human placenta (3). Some strains remain present for months to years while 
others are more transient and remain only for few days (20,21).  
Escherichia coli belongs to the phylum Proteobacteria and class Gammaproteobacteria. The 
order of this bacterium is Enterobacteriales, the family is Enterobacteriacea and the genus is 
Escherichia. It is a Gram-negative rod-shaped bacterium belonging to the group of facultative 
anaerobes.  Facultative anaerobes are bacteria which prefer to grow in the presence of oxygen, 
but that can continue to grow without it. It is accustomed to a pH of 7 to 8 and a body 
temperature of 37Cº.   
Despite E.coli being one of the best characterized model organisms, it is not only a collection 
of strains growing in laboratories. In the wild its total population size has been estimated to be 
approximately 10
20 
(4).This bacterium can be classified into major phylogenetic groups and has 
a high level of genotypic and phenotypic diversity. Most strains of E.coli are commensal, but 
others can adopt the form of a deadly pathogen. With genome analysis from twenty different 
E.coli strains, it was found that the average E.coli genome contains 4721 genes, but that only 
2000 genes with high homology are shared between all strains. This set of conserved genes 
was named the core genome (22). 
Currently, E. coli strains present in human and animal populations are divided into four major 
recognized phylogenetic subgroup : A, B1, B2 and D (4,23). In humans, considerable variation 
has been observed in the proportions of E. coli subgroups during the past 20 years (4).  
E. coli pathogenic strains are divided into several pathotypes, such as enterohemorragic, 
enteropathogenic, enterotoxigenic, enteroinvasive and extraintestinal pathogenic E.coli (24,25). 
Pathogenic strains of E.coli can cause urinary tract infections, gastroenteritis, neonatal 
meningitis, hemorrhagic colitis, multifactorial hemolytic uremic syndrome, peritonitis, mastitis, 
septicemia and other diseases (26). 
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The commensal E.coli used in this study belongs to the group A. It has a rapid growth rate in 
lab conditions, well-established genetics and the complete genomic sequence has also been 
determined. These features make it one of the most well-known model organisms. The 
relevance of studying E.coli comes from the fact  of this being the perfect candidate to study the 
transitions in the interaction between bacterium and the host, which can fluctuate between 
mutualism, commensalism or opportunistic pathogenesis (4). 
 
2.1 Microbiota – Host interactions 
 
In the natural environments, many abiotic as well as biotic factors shape the environment to 
which microbes adapt. 
Colonization and maintenance of bacteria in the mammalian gut can be influenced by many 
factors. These factors include the host immune system, nutrients, oxygen level, pH, 
temperature, the presence of antibiotics, diet from the host or even the competition and 
cooperation between the members of the microbiota.  
Normally, the microbiota remains stable for months, and possibly even years (27). However 
the stability of these microbial communities can be quickly and profoundly altered by common 
human actions and experiences (28). 
Two bacterial phyla, the Firmicutes and the Bacteroidetes, commonly dominate this human 
gut complex ecosystem(29), as they do in the guts of at least 60 mammalian species (30). 
These commensal microbes can have many functions in the cooperative process such as 
training the immune system. Despite the symbiotic nature of this association, the dense 
communities of bacteria from the microbiota can try opportunistic invasion of the host tissue and 
cause serious health consequences to the host. There are several examples like commensal 
E.coli, which is present in the microbiota from the gastrointestinal tract, where it normally does 
not cause disease (8). Nevertheless, even commensal E. coli can become an opportunistic 
pathogen if it breaks hosts physiological barriers, causing urinary tract infections or sepsis (31). 
Other opportunistic pathogens such as Candida sp and Clostridium sp also fulfil a beneficial role 
in the gastrointestinal tract when at a low level, by contributing to the maturation of the immune 
system; nevertheless, when perturbed the microbiota balance, they could incite disease(32). 
 
The immune system has evolved adaptations to keep the balance in the microbiota and 
preserve the homeostatic relationship between host and microbiota (33). The microbiota is 
thought to have other functions like the vitamin production and harvest of otherwise unavailable 
nutrients sources (34).  It is described as even preventing pathogen infection (35). Gut 
microbiota can provide protection to its host, working as a physical barrier to incoming 
pathogens by competing for the attachment sites, or consuming the nutrient sources, and 
producing antimicrobial substances (14). 
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Gut microbiome can be modulated by dietary changes, antibiotic use, or disease (28), 
disrupting the balance between the microbiota and the host. Identifying specific disease-
associated signatures in the microbiome as well as the factors that alter the microbial 
populations and gene expression will lead to the development of new products such as 
prebiotics, probiotics or other drugs to treat these disorders. The World Health Organization has 
defined probiotics as the “live microorganisms that can provide benefits to human health when 
administered in adequate amounts, which confer a beneficial health effect on the host” 
(WHO/2001). Another way of shaping a healthy microbiota is through the use of prebiotics. 
These are composed of oligosaccharides that the host cannot digest and that can have a 
beneficial effect on health through the selective stimulation of growth and/or activity of specific 
members of the gut microbiota (36). Live bacteria (probiotics) and prebiotics can be 
administered together in order to improve their function, and consequently improve the health 
benefits to the host (37). 
For instance, probiotics can modulate the immune system by increasing the production of 
pathogen-fighting antibodies and other immune cells. They are also able to enhance the 
function of intestinal cells by stimulating them to produce more mucus and protecting them from 
dying off. Other studies have shown how probiotics can act as antimicrobial agents by 
suppressing the growth and invasion of harmful pathogens. From a therapeutic point-of-view, 
probiotics and prebiotics have been reported to help in the treatment of numerous 
gastrointestinal disorders (for more information see Vieira et al (37)). However, further tests for 
potential side effects both in the host and in the bacteria are still necessary. 
 
2.2 Microbiota in disease 
 
Nowadays research efforts focused on elucidating the contributions of the gut microbiota to a 
considerable number of complex diseases. Studies on obesity for example have revealed that 
diet can affect the gut microbial composition(29) or that microbiome from an obese can have 
increased capacity to harvest energy from the host diet (38). Several other diseases like 
allergies, type 1 diabetes, inflammatory bowel disease or even autism are now beginning to be 
associated with microbiota disruptions ( for more details see Serikov et. al.(14)). 
The disruption of the microbiota created by the administration of antibiotics or by a disease 
has the potential to adversely affect the function of multiple host organ systems for a prolonged 
period of time (14). Additionally, exposure of the microbial inhabitants of the gut to various 
antibiotics is likely to result in the acquiring of multiple antibiotic resistances by these 
commensal bacteria, which can further delay or prevent the return to equilibrium if the same 
antibiotic regimens are administered repeatedly. Furthermore, it can promote the spread of 
antibiotic resistance among pathogenic bacteria that will come in contact with the antibiotic-
resistant microbiota (14). 
 
  
10 
 
 
Strategies that try to restore the normal gut microbiota have been extensively studied in 
human and animal models, as these methods represent a valuable tool to treat several 
disorders. One of these techniques is the fecal microbiota transplantation (FMT) which consists 
in the transference of a fecal suspension from a healthy person into the gastrointestinal (GI) 
tract of another person to restore the microbiota and possibly cure a specific disease. 
Successful examples of applying this strategy have been accumulating with one of the most 
important being the effectiveness of fecal transplantation to patients with recurrent Clostridium 
difficile infections(39–41). These studies are being performed all over the world in order to 
understand the capacity of this treatment to cure other diseases. 
 
3. Selective Pressures experienced in the gut 
 
Given E.coli’s potential to adapt to simple abiotic and complex biotic environments, it is 
important to understand which type of selective pressures it encounters in its natural 
environments. The selective pressures in the habitats of commensal strains may coincidentally 
promote the emergence of virulence factors and antibiotic resistance. 
3.1 Nutrient availability as selective pressure in bacterial populations 
 
As genetic information contained by the myriad of gut microbes encodes for a far more versatile 
metabolome than that found in the human genome (42), nutrient availability will be an important 
feature that can influence their maintenance in the gut.  While studying the mechanisms that 
control bacterial populations in continuous-flow culture models of mouse large intestinal flora 
Freter et al (43) concluded  that the competition for resources is a very important factor, leading 
him to propose the nutrient-niche hypothesis. This theory postulates that each individual 
species has a preference for one, or a few nutrients present, creating a nutrient-defined niche 
occupied by an individual species (43). In other words the gut is a balanced ecosystem in which 
only one species can occupy one of the numerous intestinal niches presented. As a 
consequence, the size of the populations of individual species is assumed to be determined by 
the availability of the preferred nutrient. The relatively low population size of E.coli in the 
intestine indicates that the concentration of its preferred nutrients is low (44,45). 
 
In the large intestine, bacteria grow on nutrients acquired from the mucus layer (44–46). By 
performing gene expression profiles of E.coli MG1655 while growing in mucus, Chang et al (44) 
identified which genes were up-regulated in this situation. The main targets were genes 
involved in catabolism of NAG, sialic acid, glucosamine, fucose, ribose, glucuronate, 
galacturonate, gluconate and maltose.  In the same work Chang et al described which subset of 
carbon sources is mostly likely to be involved in E.coli’s colonization and maintenance in the 
gut. They proposed gluconate as the major carbon source for colonization whereas glucuronate, 
mannose, fucose and ribose proved to be important for E.coli’s maintenance. Therefore they 
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concluded that colonization of the mouse gut by E. coli MG1655 is supported, to various 
degrees, by at least seven mucus-derived carbon sources. These carbon sources were used by 
us, to test for adaptive phenotypes of E.coli, in in vitro competitions (results-section3). 
 
3.1.1 Specialists vs Generalists 
 
An additional level of complexity in evolutionary studies is added when abiotic environmental 
conditions change over time and space (47–49), which is very likely to be the case of the gut. 
An interesting example of an in vitro experiment where this problem was addressed is the work 
by Cooper and Lenski (47) where they studied 42 populations of E. coli propagated for 2,000 
generations either on single carbon sources (glucose, lactose or maltose) or in combination of 
two carbon sources (glucose and maltose or glucose and lactose) presented together or 
fluctuating daily. Interestingly, they found that populations adapting to fluctuating environments 
showed greater fitness variation among populations than in constant environments. Regarding 
to the specific carbon sources, populations evolved in glucose improved the least, whereas 
populations evolving in maltose or lactose showed the largest fitness increase, even when 
compared with the respective mixture with glucose, so the mutants specialize in one carbon 
sources. 
 
In spatially structured environments mutants can evolve that are better adapted to particular 
regions and/or particular nutrients. In contrast in continuous nutrient-limited environments, 
theory predicts the selection of strains that scavenge the limiting resources or more efficiently 
convert that resources (50). It is recognized that whereas adaptation to pure carbon sources 
can favor the evolution of specialists, adaptation on mixed carbon sources provides an 
opportunity for generalists to evolve. 
 
Given this, what can be expected in the complex environment that is the gut? What is the trait 
that we possibly will observe in there? Will they be specialists or generalists?  
 
While specialists are the best in one specific environment, that is, at metabolizing one single 
carbon source, generalists can metabolize a variety of them. The drawback of being a specialist 
is the cost of the adaptation, which could be deleterious in a different environment. On the other 
hand being a generalist brings the problem of the generalization costs, that means they can 
grow in several different environments but cannot be the fittest in none of them (51). 
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3.2 Oxygen levels as selective pressure in the mammalian gut 
 
Other type of pressure influencing the microbiota present in the gut is the oxygen level. 
Oxygen tension is low in the intestine. Using several specific techniques He et. al.(52) was able 
to map spatial differences in oxygen tension inside the gut. These measurements revealed a 
marked oxygen gradient from the proximal to the distal GI tract. Their hypothesis to explain this 
observed oxygen gradient along the GI tract is a combination of several processes. From the 
swelling of food to the transition to the stomach and then to the small intestine, oxygen levels 
fall, as oxygen diffuses across the mucosal membrane. On the passage to the colon the 
presence of bacteria will decrease even more this oxygen tension, being almost none in the 
distal part of the lumen of the colon.  
Anaerobic respiration during evolutionary history use compounds such as fumarate, nitrate 
or succinate as electron acceptors. After the rise of atmospheric oxygen concentration caused 
by the metabolism of photosynthetic organisms, aerobic respiration emerged using oxygen as 
terminal electron acceptor. Since oxygen has a higher redox potential than the electron 
acceptors used in anaerobic respiration it permits the release of more energy per oxidized 
molecule. Several types of oxidation-reduction enzymes participate in this electron transport. 
These include NADH dehydrogenases, flavoproteins, iron-sulfur proteins, quinone, cytochromes 
in aerobic pathway and reductases as nitrate and fumarate reductases in the anaerobic electron 
transport pathway (53). 
Through the possibility of the presence of oxygen in the intestine other experiments where 
done in order to understand E.coli’s (a facultative anaerobe) metabolism in the intestine. It was 
observed that E.coli lacking the high-affinity cytochrome bd oxidase (used when oxygen tension 
is low) failed to colonize the mouse intestine. On the other hand the low-affinity cytochrome bo3 
oxidase (used when oxygen tension is high) was found not to be necessary for colonization. It 
was showed that other genes like the arcA, for anaerobic respiratory control, narG (gene coding 
for nitrate reductase), or even the frdA (gene coding for fumarate reductase) were all necessary 
for colonization. These observations suggest that E.coli is dependent on both microaerobic and 
anaerobic respiration, leading to the conclusion that it maximizes its growth yield by coupling 
oxidation of low nutrient concentration to respiration in the intestine (54). 
 
4. Evolutionary mechanisms that can underlie the adaptation 
 
Bacterial populations are powerful models to explore the mechanisms of evolution. E.coli is 
part of a massive variety of microorganisms that inhabit the gut. This diversity is one of the 
strongest selective pressures acting on E.coli ’s evolution in the gut (55). The ability to 
constantly adapt is crucial to survive in this complex environment(56).  
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Although E.coli is one of the predominant facultative anaerobes, how it colonizes and adapts 
growing in the intestine of mammals is still not well understood. In this work we are trying to 
understand the forces that are shaping its evolution and which is the evolutionary mechanism 
that plays a central role in such evolution. There are several well-known evolutionary 
mechanisms that can explain this adaptation. Mechanisms like mutation that are modifications 
in the gene sequence, which can occur in a myriad of ways: by single nucleotide changes, 
deletions or insertions, by duplications or translocations, or by the movement of transposable 
elements, such as insertion sequences (IS).  
 
Usually adaptation depends on the frequency at which new mutations arise in natural 
populations and their fitness effects, which are of crucial importance for endurance of organisms 
to the novel environment (57).  
 Insertion Sequences (IS) are a type of Transposable Elements (TEs) very common in 
bacterial genomes(58) and with an outstanding ability to mobilize within the host genome (59). 
These TEs are thought to be major players in the genome organization and evolution and found 
to have an important role in our experiment. Many times these elements are described as 
encoding nothing more than their own mobility. They are very common in bacterial genomes. 
Although most of their transpositions will decrease bacteria’s growth rate, they are thought to 
play a major role in bacteria adaptation processes to specific environments (60).  
 
Other important mechanism is genetic drift. It is characterized as the random sampling of 
alleles from one generation to the next, (particularly important in small populations). The 
exchange of genetic information between different strains (recombination) and natural selection 
are also important in explaining the diversity in populations. In adaptive evolution experiments, 
selection can drive different evolutionary dynamics. First if a mutation reaches genetic fixation 
before others become established,(if their rate of appearance is low relative to its fitness 
advantages and to population size) this leads to a type of dynamics called periodic selection 
(Figure 3a) (61). However if the rate of beneficial mutations appearance is high (62), it is very 
unlikely that one beneficial mutation can reach fixation before another appears in another 
lineage. In asexual populations this means that these two mutations will compete between 
them, thus decreasing the probability of fixation. This effect is called clonal interference and 
gives rise to a type of dynamics characterized by soft genetic sweeps, where multiple adaptive 
alleles at the same locus that can sweep through the population at the same time (5,63)(Figure 
3b).  
Selection is so strong that even with more than one beneficial mutation appearing; one 
mutation outcompetes the others and gets fixed in the population. This effect translates into 
dynamics with hard genetic sweeps (Figure 3c).  
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Dynamics can be driven by ecological interactions within and between species like the ones 
that can be anticipated to occur in the intestine. These interactions can lead to negative 
frequency dependent selection. Negative frequency-dependent selection translates in fitness 
advantage of clones when at low frequency but fitness disadvantage when at high frequency. 
Importantly this will lead to maintenance of genetic diversity (64–66). 
 
The evolutionary mechanisms presented above have been mostly described for evolutionary 
experiments in vitro. It is of upmost importance to understand their importance when in a natural 
scenario like the gut. 
 
5. In vitro vs In vivo experimental evolution 
 
In vitro experiments are really important for evolutionary biology because they provide an 
enormous level of simplification allowing the investigator to focus in only a specific 
trait/component. In our case we will test one by one, the potential metabolic pressures faced by 
E.coli inside the mammalian gut. Although many issues can be addressed by in vitro 
experiments, these are normally too focused in only one trait but in order to address a natural 
environment with all the interactions biotic and abiotic, in vivo experiments have to be 
performed and so we did in order to understand evolutionary mechanisms underlying the 
E.coli’s adaptation to the gut and to understand the rate of this process in a natural 
environment.   
Figure 3 –Genetic dynamics in evolution experiments in asexual organisms  adapted from Barrick JE and 
Lenski RE in (50). a – Periodic selection regime. b- Clonal interference, giving origin to “soft sweep” 
mutations. c- If strong selection is periodicaly imposed, in ways that may be lethal to most of the population 
(shown by dashed vertical lines), named of “hard sweeps”. 
 
15 
 
 
One of the most used model organisms to address issues related with the microbiota is the 
mouse. In this thesis we use streptomycin-treated mice. Streptomycin mimics a typical 
inflammatory environment in the intestine, showing a decrease in the microbial richness and 
diversity and being accompanied by a reduction in obligate anaerobic bacteria creating an 
enabling environment for the outgrowth of facultative anaerobes like E.coli. In short, 
streptomycin opens a previously unavailable niche, which can then be colonized by newly 
introduced microorganisms such as E coli (67,68). 
 
In the present work we study the genetic basis of the adaptation of E.coli in two consecutive 
colonizations of the mouse gut. Fifteen streptomycin-treated mice were “gavaged”
1
 in each 
colonization, with a co-culture of two strains of E.coli, each marked by a chromosomal encoded 
fluorescence and otherwise genetically identical. The strain used in the second colonization was 
a selected clone from the last time point (isolated from one mouse) of the first colonization. The 
genetic basis was described by performing Whole Genome Sequencing (WGS) and the effect of 
the parallel mutations on gene expression, specifically the effect of the insertion of IS elements 
in regulatory regions was quantified by RT-qPCR. We found that some mutations have a 
differential effect in the gene expression dependent of the oxygen levels present in the medium. 
Some genes revealed to be more expressed when in anaerobiosis and others in aerobiosis 
enlightening the complexity of the oxygen levels inside the gut.  We also determined the 
haplotype diversity during the adaptation to better understand the dynamics of adaptation. The 
haplotype diversity (from 4 and 3 analyzed populations from first and second colonization 
respectively) shows a regime of clonal interference. The number of haplotypes emerging in the 
first colonization was higher than the number in the second colonization. Furthermore we 
investigate the potential metabolic pressures faced by E.coli when inside the gut, growing the 
evolved clones from both colonizations in different environments comprising single carbon 
sources and a combination of carbon sources described to be present in the intestine (44). 
 
 
 
 
 
 
 
 
 
 
 
1
Direct delivery of a suspension of cells to the stomach by means of a tube 
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Results 
 
1. Neutral marker dynamics during the first and second steps of adaptation of 
Escherichia coli to the mouse gut 
 
As an adaptive walk is expected to involve more than one adaptive steps, we have studied 
the adaptive evolution of E.coli corresponding to the first and second steps of adaptation to the 
mouse gut. The first step was obtained by using a commensal lab strain of E. coli (K12, 
MG1655) to colonize fifteen mice and allow it to evolve for 432 generations (5). For this, mice 
were gavaged with a mixture of equal amounts of two isogenic strains of E.coli except for a 
chromosomally encoded fluorescent protein (CFP or YFP). Next the frequency of the neutral 
markers was followed by platting the fecal pellets sampled from each mouse every day for 24 
days (~432 generations) and counting the number of CFP and YFP colonies (dynamics are 
shown in Figure 4A). 
 
Following the first period of adaptation we isolated a clone from each mouse and performed 
WGS. This allowed us to select a clone from the last time point bearing a SNP and a duplication 
(see table S2.1 – clone 12YFP). Duplications are highly unstable when displaced from the 
environment where they were selected. Therefore, while genetically manipulating the clone 
12YFP to reestablish the polymorphism for the neutral marker, the duplication was completely 
lost. This was a necessary procedure to obtain the ancestors of the second adaptive step, two 
isogenic clones (except for the fluorescence marker) differing by a single mutation from the 
ancestors of the first adaptive period.  
 
The second adaptive step was performed in the same way as the first except for the strains 
used to colonize the mice (marker dynamics showed in Figure 4B). Some of these dynamics 
exhibit an initial increase in frequency of one of the neutral markers, followed by replacement by 
the subpopulation bearing the other marker (example Figure 4A, population 1.9 and Figure 4B, 
population 2.12), this was interpreted as a typical signature of clonal interference (CI). This 
replacement is assumed as the markers hitchhike with the successions of beneficial mutations 
(69). Within these dynamics was also observed cases in which the frequencies of the markers 
remained stable (example Figure 4A, population 1.6 and Figure 4B, population 2.14) during the 
24 days of the adaptive period. The stability of the neutral markers can be expected under 
different adaptive scenarios: lack of occurrence of beneficial mutations leading to neutral 
evolution or in contrast, as the occurrence of strong mutations of similar effect in both 
backgrounds at the same time. This later causes an intense process of CI but looks similar to 
the neutral dynamics. 
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In order to distinguish between the two scenarios and to further show that strong adaptive 
mutations were occurring we performed in vivo competitive fitness assays between a mixture of 
evolved clones (subpopulation labelled with the same neutral marker and isolated from the 
same mouse) and the respective ancestor clone (either from the  first colonization (5) or second 
colonization (Fig.5)) labelled with the opposite marker. We tested populations where a clear 
signal of adaptation (that is a rapid deviation from the initial ratio of ~50% of one of the markers) 
was detected (Fig.5. first colonization – populations 1.12, 1.13, 1.3 and 1.11; second 
colonization – 2.3, 2.10 and 2.12) and populations where the neutral markers remained 
polymorphic (Figure 5. first colonization – populations 1.6 and 1.8; second colonization – 2.6, 
2.7 and 2.14).  
Figure 4 – Evidence for rapid adaptation A) Dynamics of marker frequency during the adaptation of E.coli to the 
mammalian gut in first colonization (1.1 to 1.15). B) Dynamics of marker frequency during the adaptation of E.coli to 
the mammalian gut in the second colonization (2.1 to 2.15). Populations shown in colors were used in in vivo 
competitive assays.  
Figure 5 – Each bar represents the result of a competition between of a mixture of thirty clones (with a given 
fluorescent marker) isolated from the respective population (indicated below each bar) and the respective ancestor 
(means selection coefficient ±2 s.e.m, n=3 for the first colonization and n=2, with the exception of population 2.3 
that the two replicates are shown separately due to its variability). These results provide direct evidence for 
adaptation and clonal interference. 
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Most clones were found to have increased fitness in comparison with the ancestor (Fig 5). 
Despite the similar results from both colonizations, two populations from the second 
colonization showed decreased competitive fitness. Sub-populations from 2.3 and 2.12 showed 
different fitness effects in competitions performed. Population 2.12 showed a fitness decrease 
when inside the gut, raising two possibilities. First, the mutations present in this population could 
only be beneficial in maintenance in the gut but deleterious at initial colonization. Secondly this 
population can be under frequency dependent selection, where the clones from the background 
sampled are beneficial if at low frequency but deleterious otherwise. Other difference between 
first and second colonization is shown by population 2.3. It shows different fitness effects in both 
independent replicate competitions, showing a fitness increase in one and a decrease in the 
other. These competitive assays are performed with subpopulations composed by thirty random 
clones sampled from the populations. These clones potentially have more than one mutation 
each and could have different genotypes which could explain the inconsistency found in 
population 2.3. From these results it is possible to understand that we still have adaptation in 
the second colonization but we cannot state if the rate of this adaptation remains constant in 
relation to the first colonization. 
 
2. Genetic basis of adaptation in the first and second steps of adaptation 
 
At the end of each colonization experiment one clone (of the most represented fluorescent 
marker) was isolated from the E.coli population of each mouse (fourteen clones from the first 
and fifteen clones from the second step). After this sampling, WGS was performed, in order to 
characterize genetically the clones from the first (5) and the second step of the adaptive 
process in vivo (Fig. 6 and Table S2). The mean number of mutations per evolved clone was 
2.3 in the first colonization (5) and 1.8 in the second colonization. This analysis showed that ten 
different mutations were found within the clones from the first colonization and fourteen in the 
second colonization. But the most striking result from this analysis was the parallelism in the 
adaptive targets (Fig.6, tableS2). The first-step-mutation inactivated the gat operon (involved in 
the metabolism of galactitol (70)) and was common to all lines. By scoring the frequency of the 
population that lost the ability to metabolize galactitol along time, we were able to trace back the 
approximate time of its emergence and the subsequent frequency increase in all lines of the 
gat-negative phenotype (see figure S1). The second-step-mutation appeared in the gat-negative 
background and typically affected one of the following targets: regulatory regions of dcuB, focA, 
arcA and yjjP and in the coding regions of oppB, radA and srlR. 
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The dcuB gene codes for a transporter, one of three transporters known to be responsible 
for the uptake of C4-dicarboxylates such as fumarate under anaerobic conditions. Its regulatory 
region was targeted by the insertion of an insertion sequence (IS) element in three independent 
clones (three different populations) from the first colonization and in three independent clones 
from the second one. focA, codes for a bidirectional formate transporter and its regulatory 
region was targeted twice in the first and second colonizations. These IS insertions occurred in 
the regulatory region of both genes and could either knock-out the gene (abolish its expression), 
decrease or increase its expression. Knocking-out the gene would narrow the range of 
substrates that E.coli is able to use under anaerobic respiration, whereas increasing its 
expression could increase the rate of intake of these substrates. 
Finally we found four independent clones in the first and three in the second colonization 
with a SNP in srlR the "sorbitol repressor". srlR is a DNA-binding transcription factor that inhibits 
the expression of the srl operon involved in transport and utilization of sorbitol. 
arcA (four clones), a transcriptional dual regulator, is part of a DNA-binding response 
regulator in two-component regulatory system with arcB or cpxA product. arcA product is a 
response regulator that represses the genes induced by aerobiosis when in anaerobic condition 
and also activates some genes induced by anaerobiosis. Its product is phosphorylated by arcB. 
A mutation in this gene could have important pleiotropic effects since without this regulator all 
the genes induced by aerobiosis would be expressed even when not needed. radA (two clones) 
codes for a recombination protein, and yjjP that encodes for a predicted inner membrane 
protein whose function remains unknown. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 – Summary of the genetic basis of adaptive mutations in the two colonizations (see table S1 for the 
complete list of haplotypes). Notice the high level of parallelism observed between clones. Identified mutations in clones 
isolated from populations from the first and second colonizations  (1.1 to 1.14 and 2.1 to 2.15 respectively) represented 
along the E.coli’s chromosome. Inverted red triangles represent IS elements insertions, green triangles represent 
deletions, red rectangles mark the genomic region duplicated in three clones and the small bars represent SNP’s. 
Genes in bold and dashed lines represent parallel targets for mutation between the first and second colonization. nX 
represents the number of clones bearing each type of mutation. 
20 
 
 
 
2.1 Quantifying the effect of parallel mutations on gene expression 
 
Several adaptive mutations were caused by the insertion of an IS element either in the 
coding or regulatory region of specific genes. IS elements were previously found knocking out 
the gat operon (5). Another case of this IS mutational event occurred in the regulatory region of 
the arcA gene (aerobic respiratory control gene). E.coli ‘s aerobic respiratory control (arcAB 
system) seems to be more important than the aerobic respiration itself when inside the gut (71) 
so an intriguing question arises regarding the effect of ISs in the regulatory region of certain 
genes. More generally we wondered about the effects of these mutations, resulting from 
adaptation to the mammalian gut, at the gene expression level.  
 
 
To address this question we determined the effect of some of the parallel insertions (Fig.7) 
by measuring gene expression level by RT-qPCR (see methods). The effects on gene 
expression were measured in aerobic and anaerobic conditions, since E.coli experiences both 
microaerobic and anaerobic conditions inside the gut (52,54). The medium in which the clones 
were grown was supplemented with a low concentration of a five carbon sources mixture 
(gluconate, sorbitol, ribose, glucuronate and mannose). Four of them (gluconate, glucuronate, 
mannose and ribose) are described as being some of the most important for E.coli metabolism 
in the gut (44). The genes chosen to test were focA, dcuB, arcA and yjjP because they were 
targeted in parallel in different populations by IS elements in the regulatory region. yjjY was also 
tested due to the fact that the regulatory region of the arcA gene is located close to this gene. 
srlA gene was also studied because it belongs to the metabolic operon of sorbitol and even 
though not directly targeted by mutation, its expression is under the control of srlR (which 
encodes for the repressor of the sorbitol operon and was one of the main targets for mutation in 
both colonizations). 
 
The RT-qPCR results showed that the IS element insertion in the focA, dcuB and arcA 
regulatory regions did not significantly altered the expression of these genes under aerobic 
condition, but a significant increase expression was observed in anaerobic conditions (P=0.006, 
0.03 and 0.01 respectively, ttest) (Fig.7). The increase expression of focA and dcuB genes 
suggests the possibility of increased efficiency of transport of C4-dicarboxylates like fumarate 
and others, which have been reported as very important for the anaerobic respiration  of E.coli 
inside the mouse gut (54). 
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The importance of anaerobic respiration is again revealed by the increase in the expression 
of arcA under these conditions. These results indicate that one of the most powerful selective 
pressures found by E.coli in the gut is probably both availability and variability of the oxygen 
levels.  Other interesting feature that should be taken into account is the fact that these three 
genes have the IS element inserted in the regulatory region that in contrast to what happened in 
the gat operon, increased gene expression, showing that IS elements not always disrupt genes 
they can also up regulate the genes(Fig. 7).  
The results also showed that yjjP gene is being up regulated (P=0.02) when in aerobic 
conditions which suggests an important role for this gene in the aerobic pathways expressed in 
the gut. yjjY expression was measured due to the fact that the mutation in the regulatory region 
of the arcA is near this gene, which could also be affected by it as it was demonstrated in 
Figure7. 
 
 
 
 
 
 
Figure 7 – Differences in gene expression caused by the insertion of IS elements. These are reported relative to 
the ancestral strain (expression=1) of the first colonization. Two of the second-step-mutations were omitted from the 
analysis because the IS element was inserted in the coding region and thus assumed to have inactivated the gene 
function. Results are shown for aerobic (blue bars) and anaerobic conditions (orange bars). All reactions included 
three biological replicates for each sample. Data were normalized by the Pfaffl method (83) using the hfq 
housekeeping gene of E.coli as a reference. Bars represent the means of three experiments ± standard 
errors of the mean (SEM).*= P value of <0.05 (ttest). 
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In the context of sorbitol metabolism the results show that srlA gene is more expressed in 
the mutant than in the ancestral strain in both aerobic and anaerobic as shown in Figure 8 (P 
=0.03 and 0.01 respectively, for details of the ttest see materials and methods). The increased 
expression of the sorbitol operon is consistent with the presence of sorbitol in the gut and with 
its importance for the success of Ecoli’s colonization. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2 Haplotype diversity during adaptation  
 
The similarity of the diversity in the dynamics, the results from the in vivo competitive assays 
and the presence of a remarkable parallelism in the mutated genes led us to question whether 
the rate of adaptation to the mammalian gut is decreasing through time. 
In addition to the detected changes in frequency of the neutral markers, we studied 
polymorphism levels of four of the adapting populations from the first colonization (5) and three 
from the second colonization in order to better understand the regime of interference. For this 
we determined the haplotype structure from the first and second colonizations as adaptation 
proceeded (Fig.9 and 10). 
For the first colonization a sample of clones (between 20 and 40 clones per time point, per 
population) was taken and the haplotypes for the mutations found in the sequenced clones 
(table S2.1) was determined by target PCR. These included determining the presence of IS 
insertions in four genes of the gat operon (gatZ, gatY, gatA and gatC), dcuB and focA, and 
SNP’s in other two gat genes and in srlR (5). In order to determine the haplotypes structure in 
the second colonization we performed whole genome sequencing (see methods) of three of the 
fifteen populations (2.7, 2.10 and 2.14) in three time points (day11 – gen198, day17 – gen306 
and d24 – gen432). We also performed target PCR for the last day of adaptation in populations 
2.7 and 2.14, based on the parallel mutations found in the sequenced clones(table S2.2) (2.7 – 
arcA and dcuB; 2.14 – arcA and focA). 
Figure 8 – Differences in the gene expression of the srlA gene.  
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Figure 9 and 10 shows the dynamics of the haplotypes in the populations studied (first and 
second colonization respectively).  
The genetic analysis from the first colonization showed the appearance of selective sweeps 
in the sampled populations. Selective sweeps reveal a very intense clonal interference which is 
caused by strong mutations of similar effects (Fig. 9) (5). Extensive haplotype diversity can be 
observed in all populations from the first colonization but for a lesser extend in populations 1.12 
and 1.5 (Fig.9C and D respectively). On the other hand the haplotype structure from the second 
colonization populations show a decrease in this interference, where the number of haplotypes 
was smaller than in the first colonization. 
 
 
Figure 9 - Graphic representation of the frequencies of newly generated haplotypes along 24 days (corresponding to 
432 generations) of evolution inside the gut during the first colonization. Shaded areas are proportional to the relative 
abundance of each haplotype. Yellow and blue shaded areas represent the two sub-populations of bacteria labeled 
either with cfp or yfp alleles. The ancestry relations between haplotypes can be inferred by the accumulation of new 
mutations in a previously existent genotype. Dash lines mark the time points in days (upper axis) or generations (lower 
axis) where the sampling took place. For the top two populations 1.1 (A) and 1.11 (B), 40 clones were sampled in 
each time point. For the bottom two populations 1.12 (C) and 1.5 (D) 20 clones were sampled in each time point. (5) 
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As Figure 10(A) shows population 2.7 has a haplotype diversity similar to population 1.5 and 
1.12 (Fig.9D and C respectively). It has at least 6 haplotypes segregating at the last time point 
but this haplotypes have only one mutation in contrast with the many double mutants found for 
the first colonization.  
Population 2.14 was the most striking because is one of the cases where the frequency 
dynamics remained stable. But in contrast to what was found in population 1.11 (Fig.9B) (with 
similar frequency dynamic) this population is not under the scenario of an intense clonal 
interference but quite the opposite. On population 1.11 we already observe approximately 10 
haplotypes at 198 generations. On the other hand in population 2.14 only one haplotype is seen 
in this time point (Fig. 10B). Population 2.14 shows less beneficial mutations, pointing to a 
slowdown of the adaptive process. 
In the end when compared with the dynamics of the haplotypes from the first colonization, 
the second colonization show a significant decrease in clonal interference in both populations 
2.7 and 2.14 (Fig. 10A and B, respectively). Besides having less mutational targets, the number 
of segregating haplotypes with only one mutated gene associated is higher than for haplotypes 
with more than one gene targeted, as observed in the first colonization. The comparison with 
the first colonization led us to infer that probably the rate of adaptation of E.coli to the mouse 
intestine is decreasing indeed although in vivo competitions could not show it. 
 
Figure 10 - Graphic representation of the frequencies of 
newly generated haplotypes along 24 days 
(corresponding to 432 generations) of evolution inside 
the gut during the second colonization (see tables S3 to 
S5 for numeric data). Shaded areas are proportional to 
the relative abundance of each haplotype. Yellow and 
blue shaded areas represent the two sub-populations of 
bacteria labeled either with cfp or yfp alleles. White 
shaded represent mutants for which the fluorescence 
background was not determined. The ancestry relations 
between haplotypes can be inferred by the accumulation 
of new mutations in a previously existent genotype. Dash 
lines mark the time points in days (upper axis) or 
generations (lower axis) where the sampling took place. 
We performed WGS for the pointed days. In addition for 
top two populations 2.7 (A) and 2.14 (B), 40 clones were 
sampled in the last time point and was performed PCR 
(see materials and methods).  
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We can also observe a distinct pattern of adaptation in population 2.10 showing dynamics of 
a hard sweep driven by a mutation in the radA gene in the YFP background (Fig. 10C) 
demonstrating a different adaptive dynamic for a second-step mutation that was never found in 
the first colonization.  Mutation in the radA gene can bring the possibility for a mutator pattern, 
and so we performed a fluctuation test (measuring the mutation rate, see materials and 
methods). The test showed no significant difference between the mutation rates from our radA 
clone (clone 25YFP, isolated from population 2.10) and its ancestral strain. These results are 
consistent with the result from the sequencing that didn’t show the presence of many new 
mutations, pattern resultant in a mutator strain. In the case of this population the second-step-
mutation was probably radA and what is observed for the rest of the adaptation period is that 
focA, srlR, arcA and yjjP were probably the third-step-mutations. This raises the question of 
what is the strength of all this mutations, an issue that should deserve future studies. 
 
3. Testing for potential change in the metabolic traits as a result of adaptation inside the 
gut 
 
Given E.coli’s potential to adapt to simple abiotic and complex biotic environments it is 
important to understand which type of selective pressures it may encounter in its natural 
environment. 
The mammalian gut is one of E.coli’s natural environments in which many factors such as 
the host immune system, oxygen level, pH, temperature, use of antibiotics, diet from the host or 
even the competition and cooperation between the microbiota members, can influence its 
colonization ability. In this section we investigate several metabolic selective pressures such as: 
the presence of five carbon sources in low concentration either in combination or alone.  
 
We performed in vitro competitive assays (see materials and methods) in minimal medium 
with a mixture of five carbon sources (gluconate, ribose, glucuronate, mannose and sorbitol) 
described as being some of the most important for E.coli´s metabolism in the gut (the first four) 
and sorbitol, due to the fact that its metabolism was one of the most targeted by mutation during 
the adaptation to the gut. This mixture was used at two different concentrations. The first 
mixture had the concentration of 0.01% of each carbon source, which amounts to a final 
concentration of 0.05% (low concentration) and a second mixture where each carbon source 
was added in a concentration of 0.1% ( a total of 0.5%, high concentration). Both low and high 
concentrations were used to address the question whether the mutants isolated from the mouse 
gut were adapted to grow in a poor environment, or if they were only adapted to the most 
important carbon sources present in there. These in vitro competitive assays give us the relative 
fitness of the mutants against the ancestor, presented as selection coefficient. This fitness can 
indicate the strength of selection of particular mutations and can indicate whether these fitness 
effects differ between different genotypes. The clones tested in these fitness assays were the 
twenty-nine clones isolated in the last time point of both colonizations (results are presented in 
table 1). 
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Legend: 
Table 1 – Fitness effects of adaptive mutants. This table shows the selective coefficient of each clone when using 
a mixture of five carbon sources (low and high concentration) or single carbon sources (low concentration). The 
carbon sources used were gluconate, glucuronate, sorbitol, mannose and ribose, carbon sources described as 
important for E.coli when inside the gut (38). This table represents the results of the in vitro competitions performed in 
aerobic conditions. Each clone is represented by its genotype and it’s organized by the most targeted mutations. In 
green are represented significant increases in fitness relative to the ancestral strain (dark-light green = major-smaller 
increase. Red are represents the fitness decreases and in yellow no difference in fitnessin comparison to the 
ancestral clone. Differences were scored as significant in comparison with the ancestor taking into account the 
standard errors of each measurement. 
genotype mix0.05 mix0.5 mannose gluconate glucuronate sorbitol ribose
gatC arcA 0.10 0.08 0.14 0.07 0.30 0.15 0.06
gatC arcA 0.11 0.05 0.17 0.17 0.14 0.01 -0.11
gatC arcA(SNP) 0.02 -0.01 0.12 0.08 0.01 -0.08 -0.07
gatC arcA cpdA 0.07 0.01 0.16 0.06 0.07 -0.01 0.25
gatC yjjP arcA 0.08 0.08 0.13 0.07 0.13 0.11 0.12
gatY yjjP yffN 0.11 0.07 0.23 0.10 0.25 0.09 0.40
gatC yjjP radA del11kb 0.07 0.07 0.15 0.18 0.24 0.14 0.56
gatC radA 0.08 0.05 -0.05 0.09 0.10 0.17 -0.13
gatcC dcuB 0.06 0.06 0.12 0.05 0.15 0.15 0.18
gatcC dcuB 0.09 0.05 0.11 0.19 0.25 0.05 0.52
gatZ dcuB 0.10 0.09 0.22 0.05 0.23 0.11 0.32
gatC dcuB 0.11 0.05 0.19 0.11 0.27 0.05 0.29
gatZ dcuB 0.10 0.05 0.18 0.14 0.17 0.09 0.20
gatC dcuB ydjL 0.07 0.07 0.10 0.20 0.25 0.12 0.63
gatC dup150kb 0.12 0.08 0.23 0.14 0.24 0.09 -0.02
gatC dup155kb 0.13 0.10 0.15 0.26 0.37 0.13 0.60
gatA srlR 0.13 0.08 0.03 0.05 0.16 0.20 0.26
gatA srlR 0.13 0.09 0.13 0.06 0.19 0.19 0.19
gatA srlR 0.09 0.05 0.02 0.14 0.18 0.17 0.08
gatC srlR oppB 0.07 0.02 0.11 0.07 0.10 0.06 -0.16
gatC srlR oppB rfaQ 0.11 0.07 0.00 0.24 0.37 0.21 0.20
gatY srlR dmsC 0.10 0.06 -0.03 0.15 0.18 0.17 0.08
gatC focA srlR 0.08 0.06 -0.08 0.14 0.31 0.30 0.05
gatZ focA del5kb 0.10 0.05 0.18 0.15 0.20 0.13 0.15
gatY focA ydaV del5kb 0.08 0.09 -0.56 0.13 0.34 0.05 0.19
gatC focA trkH -0.01 0.00 0.02 -0.14 -0.11 -0.15 -0.32
gatA garK 0.10 0.09 0.24 0.13 0.29 0.08 0.06
gatC ykgB del7kb 0.10 0.05 0.12 0.19 0.21 0.09 0.45
gatZ 0.10 0.02 0.32 0.09 0.16 0.21 0.17
increase 
neutral
decrease
Table1 shows that almost all clones were fitter growing in the mixture of the five carbon 
sources than the ancestor. Moreover we can observe that these evolved clones have a higher 
advantage when growing at a low nutrient environment than with a high concentration of carbon 
source (P< 0.001, ttest). Therefore these results are compatible with the gut being composed of 
a multitude of different carbon sources at low concentration. These observations could indicate 
that the evolved clones are adapting to be generalists in a poor-nutrient environment. 
Furthermore competitions were performed in each carbon source separately (in a low 
concentration) in order to address the issue whether the different clones would have a preferred 
carbon source. As showed in table 1, in overall, clones have preferred carbon source, having a 
higher advantage when growing in it. But this preference is not directly connected with a specific 
genotype, with the exception of the srlR (sorbitol metabolism repressor gene) mutants. Clones 
with the srlR mutation have a significant higher advantage when growing with sorbitol as the 
only carbon source then the others (P= 0.004, ttest). This advantage is due to the fact of a 
probable deficient activity performed by this repressor, as supported by an increased 
expression of srlA.  
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One other important aspect to note is the carbon sources in which more clones have 
advantage, which are the gluconate and glucuronate. Gluconate is the only in which all the 
clones have an advantage relative to the ancestor, with the exception of one clone. Supporting 
the previous observation (44) that gluconate is probably one of the major sources for E.coli in 
the gut. On the other hand ribose was the carbon source in which the fitness effects were more 
variable.  
Other peculiarity that must be noticed in table1 is the fact that the only single mutant (with 
one mutation in the gatZ) has already a great advantage in either the mixture or the single 
carbon sources, suggesting that the first step of adaptation is crucial to deal with the metabolic 
pressure faced by E.coli inside the gut. Several of the second-step mutations are targeting 
genes with relative importance in respiratory pathways and some of them have demonstrated to 
have an effect in the gene expression when in anaerobic conditions. As E.coli is known to be 
dependent on both microaerobic and anaerobic respiration inside the gut (54,71) and because 
some of the mutations seem to have an effect dependent on the presence of oxygen, in the 
future we will perform the same competitive assays under anaerobic conditions. 
This section allowed us to study the metabolic pressure alone demonstrating that in vitro 
experiments are an important supplement in order to understand the organism’s behavior in its 
natural environment. 
 
Discussion 
 
Previously we have demonstrated that E.coli can adapt very fast to the intestine of 
streptomycin-treated mice (5). This first step of adaptation was dominated by soft sweeps, 
adaptive mutations of large effect and an intense regime of clonal interference where 
haplotypes carrying either one or more beneficial mutations were competing for fixation. Among 
the mutations arising during this process a high degree of parallelism was observed not only in 
the first step, inactivation of the gat operon, but also among the targets for the second step 
(dcuB, focA, arcA, yjjP, srlR, oppB or radA). This kind of parallelism already demonstrated in 
other in vitro evolution experiments(64,65), was difficult to anticipate in such a complex 
environment as the mammalian gut. Here the bacterial community is thought to be under 
multiple selective pressures, ranging from direct competition with other bacteria, to the action of 
immune system, the oxygen level or the diet composition.  
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1. Adaptive mutations, a major role for IS elements  
 
High parallelism was found between mutations arising in the adaptation of E.coli to the 
mouse gut. The first gene targeted for mutation was one of the gat operon, which was 
inactivated in all populations (~80% of these events were caused by IS insertions(5)). This 
operon allows for the galactitol metabolism (70). In our study we use a derived strain of E.coli 
MG1655 which is a commensal K12 E.coli. This Wild-type E.coli K12 has one IS inserted in the 
gatR that disrupts the repressor of the galactitol operon, thus rendering the operon with a 
constitutive expression. The first hypothesis for this first step of adaptation is the toxicity of the 
galactitol to our strain since we have found that it had an inhibitory effect on the ancestral strain 
when grown in minimal medium with other carbon source (5). Other hypothesis was the 
principle of selection against the production of unneeded proteins (72) which suggest the fitness 
cost of the expression is proportional to the amount of protein produced, being the production of 
this useless protein a major energetic cost. The observed benefit that the gatZ mutation alone 
was able to confer in any of the poor nutritional media tested supports this idea (Table 1). 
Another example was the observation by Stoebel et al (72) that the cost in fitness, when in 
lactose absence, to E.coli strains that are constitutively expressing the lac operon is associated 
with the actions of transcription and/or translation. The presence of galactitol in the 
streptomycin-treated gut is yet unkown. If absent this could drive to the hypothesis that the 
constitutive expression of the gat operon has a cost to the cell which would be abolished by the 
disruption of the operon.  
A similar situation was observed by Zhong et al (73) when studying the evolutionary genomics 
of ecological specialization of an Ecoli K-12 strain which also has an IS inserted in gatR that 
disrupts the repressor of the galactitol operon. They found that during the specialization process 
to limiting-nutrient environment one IS was transposed into yegW gene deleting the entire gat 
operon (73). 
 
Despite the fact that this first step was mainly due to the insertion of ISs, these usually 
happened in the coding regions being in agreement with the effect of inactivation of the operon 
and the gat- phenotype. A high rate of insertion of ISs continued in the second step but unlike 
the first step these targeted mainly the regulatory regions of specific genes. The result of these 
insertions was difficult to anticipate, since they can cause: abolishing of gene expression, 
modification of the level or timing of expression or even activate genes previously inactive 
(some ISs are known to carry promoting sequences)(58). Hence we measured the level of 
expression of the genes targeted by the IS elements in the regulatory regions (dcuB, focA, arcA 
and yjjP) in aerobic and anaerobic conditions. 
 
One of the second mutations arising is in the regulatory region of the focA gene. It is 
a bidirectional formate transporter with an important role in regulating intracellular formate levels 
during anaerobic respiration. This gene is extremely important to the maintenance of the pH 
inside the cells (74). Studies of the formate levels in fermenting E.coli cultures indicate that 
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initially, formate is exported out of the cell in order to prevent acidification of the cytoplasm. 
However, if the pH of the culture medium drops below about 6.8, formate is re-imported and 
focA has also been implicated in this process (74).  
dcuB is other gene targeted by an IS in its regulatory region that is important when in 
anaerobic conditions. This gene is responsible for the uptake of C4-dicarboxylates such as 
fumarate under anaerobic conditions.  
The presence of the IS in the regulatory region of these genes (dcuB and focA) could cause 
several consequences to the cell. They could knockout the gene (as in the gat genes), or affect 
its regulation.  
The results from the expression level of both dcuB and focA gene showed that possibly the 
IS had no effect when in aerobic conditions but triggered an increase in its expression relative to 
the ancestral strain, when in anaerobic conditions (P=0.006 and 0.03 respectively, ttest). 
 
It was already shown that the use of cytochrome bd oxidase as electrons acceptor is more 
advantageous to E.coli when inside the gut. But it was also shown that E.coli uses nitrate and 
fumarate reductase when performing anaerobic respiration. It was found that, when colonizing 
the intestine, nitrate reductase mutants outcompete the fumarate reductase ones, indicating that 
fumarate is the more important anaerobic electron acceptor in the intestine because nitrate is 
limiting (71).  So taking into account these observations and our results we can hypothesize that 
C4-dicarboxylates like fumarate and other anaerobic respiration substrates are present and are 
important in the anaerobic respirations inside the gut. Our strain appears thus to be adapting by 
becoming more efficient at transporting these substrates. 
 
arcA gene is a transcriptional dual regulator, part of a DNA-binding response regulator in 
two-component regulatory system with arcB or cpxA product. ArcA product is a response 
regulator that represses genes induced by aerobiosis when in anaerobic condition and also 
activates some genes induced by anaerobiosis. An IS element was inserted in the regulatory 
region of this gene in several populations during the adaptation process. This gene is regulated 
by other important regulator gene that is the fnr. Fnr is the primary transcriptional regulator that 
mediates the transition from aerobic to anaerobic growth through the regulation of hundreds of 
genes. Generally, this protein activates genes involved in anaerobic metabolism and represses 
genes involved in aerobic metabolism (75). The derived E.coli strain that was used in this thesis 
has a deletion in the site of the genome that includes the fnr gene. The knock-out of this gene 
causes down regulation of the arcA gene (76) this fact can cause difficulties in E.coli 
colonization and maintenance inside the gut. Marzan et al (76) observed that although arcA 
mutants can colonize when fed alone to the mice, they could not compete with their respective 
wild type and were eliminated from mice within 3 days (54). The RT-qPCR analysis for this gene 
showed an increase (P=0.01, ttest) expression in anaerobic condition suggesting that 
appropriate regulation of aerobic respiratory genes is necessary for E.coli survival inside the 
gut. These facts suggest that selection for increase expression of arcA might be related with the 
absence of the important regulator fnr and/or to the low oxygen concentration in the gut.  
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The mutation in the regulatory region of the dcuB, focA and arcA genes is part of the second 
step of adaptation, this could suggest that the metabolic optimization is occurring first being the 
more important selective pressure. But then and because of the oxygen variability in this 
environment (52), where E.coli can encounter microaerobic and anaerobic conditions, becomes 
important to have respiratory flexibility (better transport of anaerobic respiration substrates and 
aerobic respiration regulation). 
Other peculiarity showed by our results is that the mutations of the regulatory region of dcuB, 
focA and arcA were never found together (in all combinations dcuB and focA, or dcuB and arcA 
or focA and arcA). This observation could reveal a process of negative epistasis between them. 
Negative epistasis happens when the effect of a beneficial mutation is bigger than the combined 
effect of two of these beneficial mutations. In the case of beneficial mutations this significantly 
decreases the probablility of finding the double mutant.  An example of negative epistasis 
between beneficial mutations is described in Chou et al (77). They studied the combinations of 
beneficial mutations that arose in a lineage during rapid adaptation of a bacterium. Results 
showed that the selective benefit for three of the four beneficial mutations consistently 
decreased when introduced upon more fit backgrounds (77). 
 
The mutation in the srlR gene is possibility due to the metabolic pressures faced inside the 
gut. The srlR gene is the repressor of the metabolism of sorbitol. The mutations targeting this 
gene were mainly SNP’s some of them causing stop codons (5), and a few small indels, 
suggesting that this gene is probably being severed. The RT-qPCR results on the srlA gene 
(sorbitol PTS permease) showed an increase in expression relative to the ancestral strain in 
aerobic and anaerobic conditions (P= 0.02 and 0.001 respectively, ttest) suggesting that the 
activity of the repressor (srlR) was severely affected. The mutants with the constitutive 
expression of the sorbitol operon will have an advantage when facing an environment with the 
presence of sorbitol which can probably be the case of the gut. 
 
The striking observation that the same IS element is targeting the same gene in different 
bacteria that are evolving in different mice questions the use of these elements as neutral 
markers of evolution. In certain cases, the localization of different specific IS elements at 
defined places in the chromosome is considered sufficiently stable to allow them to be used as 
markers in restriction fragment length polymorphism studies for species typing and for 
epidemiological purposes (e.g., IS6100 in Mycobacterium tuberculosis (78), IS200 in 
Salmonella (79) and IS1004 in Vibrio cholerae (80). In other words epidemic studies use ISs as 
neutral markers to follow pathogenic strains in an outbreak. But this technique may mislead the 
results. One of the problems is the IS hotspots that exist in E.coli genome, which are places in 
the genome that are more targeted by these transposable elements. Other issue is showed by 
our results, where the same IS is targeting the same gene but in different bacteria that are 
evolving independently in the gut of different mice, suggesting that ISs are not the best neutral 
marker to take into account for epidemiological purposes.  
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2. Selective pressures inside the gut 
2.1 Oxygen levels  
 
Oxygen level is one of the selective pressures influencing adaptation of E.coli to the gut. 
Some studies revealed that there is a marked oxygen gradient from the proximal to the distal GI 
tract (52). These observations led to the hypothesis that E.coli has being spread throughout the 
gut being a subpopulation exposed to an environment with more oxygen and other in a more 
anaerobic one. When in spatially structured environments mutants can be selected to better 
adapt to particular regions or to better colonize microhabitats. By contrast in continuous 
nutrient-limited environments, theory predicts they will be selected to scavenge the limiting 
resource or more efficiently convert that resource (50). 
Our results of gene expression showed that at least three of the second step mutations 
occurring in the adaptation of E.coli to the mouse gut are related to the respiration, suggesting 
that these clones are adapting to the oxygen variability in this environment.  
 
2.2 Metabolic Pressure 
 
Specialists and Generalists 
 
Selection in nutrient limited environments and in spatially structured environments can have 
a huge importance in microbiota balance (50). 
There are at least three mechanisms that can origin specialists (81). Clones can accumulate 
neutral or beneficial mutations, which are deleterious in another environment (mutation 
accumulation or antagonistic pleiotropy respectively) or they can accumulate beneficial 
mutations which are neutral in another environment (independent specialization). But only 
populations growing on single carbon sources can specialize by this three mechanisms, those 
who grow in mixed carbon sources (as the environment faced by E.coli inside the gut) cannot 
specialize by mutation accumulation because any mutation that have a neutral effect in one 
carbon source but a deleterious one for a second carbon source will be eliminated by selection. 
In the other hand the process of independent specialization can drive to the appearance of 
generalists (51). Our results suggest that the clones that are adapting inside the mouse gut are 
evolving to be generalists scavenging for nutrients. 
 
In addition gluconate was the only environment where all clones (except one) had a fitness 
increase relative to the ancestral, supporting the observations already described (44) that 
gluconate is one of the more important carbon sources for E.coli in the gut. On the other hand 
ribose was the carbon source in which the fitness effects were more variable. It was already 
observed that the metabolism of ribose both in vitro and in vivo can sometimes be regulated by 
the presence of other carbon source also important for E.coli inside the gut, fucose (44,82). 
Taking in account this information it is possible that some of the isolated clones evolved with the 
presence of the two carbon sources and so are adapted to the regulation set by fucose to the 
metabolism of itself and ribose, which could explain that variability within the clones. 
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3. Evidence for continuous adaptation of E.coli in the mouse gut 
 
A common result from in vitro evolution experiments is that the rate of adaptation tends to 
slow down over time, in other words the fitness increases tend to decelerate over time. An 
example is the long-term experiment where twelve E.coli populations were evolved in glucose 
and the fitness was measured during the adaptation process. The average fitness gain in the 
first 5000 generations revealed to be approximately tenfold greater than the one between 15000 
and 20000 generations (83). 
This can be due to the diminishing of the number of beneficial mutations or the fact that its 
effect is smaller. Actually this is observed when the first step of adaptation is bigger than the 
second over the adaptive walk and then the second being bigger than the third consecutively. 
So it would be plausible that this would happen in the adaptation of E.coli to the mouse gut.  
 
With further analysis of the haplotype diversity over time from the second colonization was 
observed that although soft sweeps were described they were in a small number. In other words 
the number of haplotypes with different beneficial mutations competing with each other is lower, 
suggesting the presence of clonal interference but with a smaller strength.  
 
The process of adaptation can be quite complex as described in Good et al (84), who 
modelled clonal interference. Populations with a rate of mutation very small present a lower 
number of beneficial mutations enabling the existence of only one mutant in the population at a 
true classic periodic selection regime. On the other hand in large populations like the one from 
this study, a much more complicated situation occurs in those distinct mutations segregate 
simultaneously (84), many of them competing for fixation. These dynamics can create a 
complex process of interference, which was observed during the first colonization of E.coli to 
the mouse gut (5). This interference is still occurring in the second colonization but possibly with 
a smaller strength due to the fact that the number of beneficial mutations observed is smaller 
than in the first colonization. 
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Conclusions  
 
In conclusion we demonstrate here that E.coli MG1655 continues to adapt in a second 
colonization to the gut of streptomycin-treated mice but with differences in the target genes and 
in the adaptive dynamics. The second-step mutations appearing in the second colonization 
targeted not only dcuB, focA and srlR that were already described in the first as other new 
targets radA, arcA, oppB and yjjP. This second colonization analysis has also demonstrated the 
presence of soft-sweeps but with inferior clonal interference than the one showed in the first 
colonization. For example 33% of the sequenced clones from the second colonization carry only 
one beneficial mutation, in contrast to the first colonization where only one out of 14 clones was 
a single mutant.  
We demonstrate here that IS elements play an important role in E.coli’s adaptation to this 
complex environment. Bacterial insertion sequences were initially identified during studies of 
model genetic systems by their capacity to generate mutations as a result of their translocation. 
Several studies have revealed an important role for these mobile elements in the genome of 
bacteria. For example they were found to be associated with many pathogenic and virulence 
functions, the participation in chromosome rearrangements and in plasmid integration (for more 
information see Mahillon J. 1998(58)). The evolutionary role of these transposable elements is 
still controversial. 
Regarding the gut environment our results suggest that oxygen level and the metabolic 
pressures are an important stimulus in the adaptation.  
Our results demonstrate the remarkable parallelism in the adaptation of E.coli to the mouse 
gut. Therefore, highly complex, the repeatability of evolution in the gut environment shows that 
parallel evolution is not restricted to idiosyncratic laboratory environments and may be very 
common in nature.  
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Materials and Methods  
 
Ethics statement 
All experiments involving animals were approved by the Institutional Ethics Committee at the 
Instituto Gulbenkian de Ciência (project nr. A009/2010 with approval date 2010/10/15), following 
the Portuguese legislation (PORT 1005/92), which complies with the European Directive 
86/609/EEC of the European Council.  
 
Bacterial Strains 
 All strains used were derived from MG1655, a K12 commensal strain of Escherichia coli .  
In the first colonization experiment (used in this experiment) the fluorescent strains MG1655-
YFP and CFP (MG1655, galK::YFP/CFP amp
R
 , str
R
 (rpsl150), ΔlacIZYA) were used for 
colonization. The second colonization started with a descendant from the first colonization that 
differs from the first ancestral by one mutation (Ins (1bp) gatC). 
 
Fluorescent marker dynamics during mouse colonization  
To study E. coli adaptation to the gut we used a streptomycin-treated mouse colonization 
model (Conway et al 2004). Briefly, 6- to 8-week old C57BL/6 male mice raised in specific 
pathogen free (SPF) conditions were given autoclaved drinking water containing streptomycin 
(5g/L) for one day. After 4 hours of starvation for water and food the animals were gavaged with 
100 µl of a suspension of 10
8
 colony forming units (CFUs) of a mixture of YFP- and CFP-labeled 
bacteria (ratio 1:1) grown at 37°C in brain heart infusion medium to OD600 of 2. After the gavage, 
all the animals were housed separately and both the water with streptomycin and the food were 
returned to them. Mice fecal samples were collected for 24 days diluted in PBS, a sample was 
stored in 15% glycerol at 80ºC and the remaining was plated in Luria Broth agar (LB plates). 
Plates were incubated overnight at 37ºC and then with the help of a fluorescent stereoscope 
(SteREO Lumar, Carl Ziess) the fluorescent colonies were counted helping to assess the 
frequencies of CFP- and YFP-labelled bacteria. 
Fifteen mice were gavaged the same way for the first and second colonization, using only 
different strain as ancestral (see bacterial strains). 
 
In vitro competitions 
The evolved clones used for the in vitro competitions were isolated from the last day (day 24 
approximately 432 gen) of the two colonizations, one from each population. These clones were 
subsequently whole genome sequenced and therefore their genotype was determined. To test 
for fitness advantage of these evolved clones, we competed them with the ancestral of the first 
step of evolution (5) labelled with a different marker. Three independent competitions were done 
for each clone. The competition environment was M9 minimal medium (M9-minimal salts, 5x - 
sigma *) supplemented with either sorbitol (dulcitol, sigma D0256), ribose (D-(-)-Ribose, sigma 
R7500), mannose (D-(+)-Mannose,99%, Alfa Aesar A10842), gluconate (Gluconic acid 
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potassium salt, Merck KGaA 8.20601.0500) or glucuronate (D-Glucuronic acid sodium salt 
monohydrate, sigma G8645) at low concentration (0.02%). Additionally two mixtures with 
different total amounts of the previous carbon sources (composed of either 0.01% or 0.1% from 
each of the five carbon sources) were also tested. All competitions were conducted in 96-well 
plates incubated at 37ºC with aeration (Thermoshaker PHMP-4, Grant). The cultures used for 
the competitions were previously grown for two overnight growths (first-24h, second-16h) in MM 
supplemented with glycerol (0.02%). Competitions were performed by inoculating between 10
5
-
10
6
 cells of both competitor and reference strain (in a ~50-50% ratio) in culture medium and 
allowed to grow for 24 hours. The initial and final ratios of both strains were determined by flow 
cytometry, using a BD LSRFortessa (BD Biosciences) cytometer. Fitness of the evolved clones 
was estimated as s (selection coefficient): 
 
 
 
Where Ni is the initial number of bacteria in the competition, and the Nf the final number of 
bacteria present in the end of the competition. Where ev represents the evolved clone and the 
ref the ancestral strain, and the gen represents the generation number. 
 
Statistical analysis: the data resented in this section represent the means of three 
experiments ± two standard errors (2se). A Paired with one-tailed distribution t test was used to 
determine the significance of the differences in fitness increase between the two different 
mixtures(0.05% and 0.5% of carbon source), with a significance defined as P value of <0.05. 
And a Two-sample unequal variance (heteroscedastic) with one-tailed distribution t test was 
used to determine the significance of the differences in fitness increase  between the with the 
srlR mutations and the others when growing with sorbitol as the only carbon source, with a 
significance defined as P value of <0.05. 
 
*(33.9g/L Na2HPO47H2O+15g/L KH2PO4 +5g/L NH4Cl +2.5g/L NaCl)) 
 
 
In vivo competitive assays of YFP or CFP sub-populations isolated from the last time 
point of the first and second colonizations 
Sub-populations of either YFP or CFP clones isolated from the last point of the first and 
second colonizations, were competed against the respective ancestor (that is either the 
ancestor of the first or second colonization) labelled with the opposite fluorescent marker. These 
sub-populations were composed of mixtures of approximately 30 colonies with the same 
fluorescent marker (population of clones) collected from mouse fecal platings, grown in 10 ml of 
Luria Broth medium (LB) supplemented with ampicillin (100 µg/ml) or chloramphenicol(100 
µg/ml)  and Streptomycin(100 µg/ml)  and stored in 15% glycerol at -80ºC.  
s = ln (Nfev / Nfref) / (Niev / Niref) * Gen-1 Gen = log2 (Nfref / Niref) 
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The isolated populations were competed against the ancestral strain labeled with the 
opposite fluorescent marker, at a ratio of 1 to 1. For the second colonization these numbers 
were confirmed by flow cytometry, using a BD LSRFortessa (BD Biosciences) cytometer. 
After gavage, the animals were housed separately and both food and water containing 
streptomycin were returned to them. Mice fecal pellets were collected for 3 days, diluted in PBS 
and frozen in 15% glycerol at -80ºC. Then the final numbers were assessed by fecal plating for 
the first colonization following the same proceedure described for the evolution experiments and 
for the second colonization the final numbers were again determined by flow cytometry, using a 
BD LSRFortessa (BD Biosciences) cytometer. 
The selective coefficient (fitness gain) of these clones in vivo (presented in figure 2B) was 
estimated as:  
 
 
Where sb is the selective coefficient of the evolved clone, Rfev/anc and Riev/anc are the ratios of 
evolved to ancestral bacteria in the end (f) or in the beginning (i) of the competition an t is the 
number of generation per day. We assume t=18, in accordance with the 80 minute generation 
time estimated in previous studies on E.coli colonization of streptomycin-treated mouse (86,87) 
 
Whole genome re-sequencing and mutation prediction 
Clone analysis: After 24 days of gut colonization one clone from populations 1.1 to 1.14 from 
the first colonization, the two ancestors (MG1655-YFP and MG1655-CFP) and one clone from 
populations 2.1 to 2.15 from the second colonization were isolated and used to seed 10 mL of 
LB (Line 1.15 was not analyzed since the mouse from this line died at that time point). These 
cultures were then grown at 37ºC with agitation. Subsequently DNA was isolated following a 
previously described protocol (Wilson K. 2001). The DNA library construction and sequencing 
was carried out by BGI. Each sample was pair-end sequenced on an Illumina HiSeq 2000. 
Standard procedures produced data sets of Illumina paired-end 90 bp read pairs with insert size 
(including read length) of ,470 bp. Genome sequencing data have been deposited in the NCBI 
Read Archive, http:// www.ncbi.nlm.nih.gov/sra (accession no. SRP017347). Mutations were 
identified using the BRESEQ pipeline (88). To detect potential duplication events we used 
ssaha2 (89) with the paired end information. This is a stringent analysis that maps reads only to 
their unique match (with less than 3 mismatches) on the reference genome. Sequence 
coverage along the genome was assessed with a 250 bp window and corrected for GC% 
composition by normalizing by the mean coverage of regions with the same GC%. We then 
looked for regions with high differences (>1.4) in coverage. Large deletions were identified 
based on the absence of coverage. For additional verification of mutations predicted by 
BRESEQ, we also used the software IGV (version 2.1) (90). 
 
 
sb =  ln ((Rfev/anc)/(Riev/anc))/t 
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 Ancestral genome: The sequence reads from MG1655 were mapped to the reference strain 
(91).The two ancestors carried the mutations listed in Table S1. The mutations underlined were 
present in the YFP ancestor but not in the CFP. The sequences of the fourteen sequenced 
clones from the first colonization and the fifteen for the second were then interrogated against 
this ancestral genome and the mutations identified are listed in Table S2. 
 
 Population analysis: DNA isolation was obtained in the same way as described above for the 
clone analysis except that instead of one clone per population a mixture of >1000 clones per 
population was used. From the second colonization three populations were sequenced: 2.7, 
2.10 and 2.14. Populations were sequenced for three time points during the adaptive period 
(generation 198 (day11), generation 306 (day17) and generation 432 (day24)). From The DNA 
library construction and sequencing was carried out by the IGC genomics facility. Each sample 
was pair-end sequenced on an Illumina MiSeq Benchtop Sequencer. Standard procedures 
produced data sets of Illumina paired-end 250 bp read pairs. The mean coverage per sample 
was as ~100x for population 2.7, ~100x for population 2.10 and, ~100x for population 2.14. 
Mutations were identified using the BRESEQ pipeline with the polymorphism option on. The 
default settings were used except for: a) require a minimum coverage of 3 reads on each strand 
per polymorphism; b) eliminate polymorphism predictions occurring in homopolymers of length 
greater than 3; c) eliminate polymorphism predictions with significant (P=0.05) strand or base 
quality score bias. 
 
Identification of adaptive mutations and estimate of haplotype frequencies in selected 
populations of the first and second colonizations 
In order to estimate the haplotype frequencies depicted in Fig. 4, depending on the 
colonization, one or two strategies were employed. For the first colonization target PCR of 
parallel mutations was performed and for the second colonization, in addition to target PCR, 
WGS of populations was also obtained. For the target PCR between 20 to 40 clones per time 
point were isolated. All time points of the first colonization and the last time point of populations 
2.7 and 2.14 of the second colonization were analyzed by target PCR. Samples isolated from 
the populations of the second colonization were WGS in all time points. The isolation procedure 
consisted in diluting the frozen fecal samples in PBS and plating the appropriate dilution in LB 
agar plates supplemented with streptomycin (100 µg/ml), and incubating overnight at 37˚C. The 
frequencies of CFP or YFP bacteria were measured by counting the CFUs in a stereoscope 
(SteREO Lumar, Carl Zeiss). 
Mutations were screened by PCR (see primers in table S6) followed by electrophoresis in 
1% agarose gel, at 50V for 1h30min. IS insertions can be scored simply by an increase (around 
700-1500bp) in the PCR fragment. srlR gene was sequenced using ABI 3130XL and ABI 377 
Automatic Sequencer. 
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The PCR reaction conditions were as follows: one cycle at 95ºC for 3 min followed by 34 
cycles of 95 ºC for 30 seg, 60 ºC for 30 seg, 72 ºC for 2 min, followed by 72ºC for 5min. PCR 
reaction: 1U Taq polymerase,5 µl buffer Taq (10x), 1 µl dNTPs (10mM), 1 µl each 
primer(Forward and reverse 10 µM), 1 µl of DNA (colony diluted in 10 µl ddH2O) and enough 
ddH2O to a final volume of 50 µl.  
 
 
Test for increased mutation rate 
To test for the possible mutator phenotype of the clone 25YFP ([insX-insA], yjjP/yjjQ, radA – 
isolated from population 2.10) (table S2) we determined the frequency of rifampicin-resistant 
mutants. This was done by growing pre-cultures (10 replica) of the clone 25YFP in 10 ml of LB 
overnight at 37ºC with aeration. Approximately 1000 cells of the pre-cultures were used to 
inoculate 1 ml of LB and incubated overnight. Aliquots of each tube were plated in LB agar and 
LB agar supplemented with rifampicin (100 µg/ml) and incubated overnight at 37ºC. The 
frequency of spontaneous resistance to rifampicin was calculated as the ratio between the 
number of rifampicin resistant mutants and the total number of individuals in each plate. The 
same procedure was applied to the ancestral clone so both rates of the spontaneous resistance 
to rifampicin could be compared. 
 
 
Gene expression  
Clones 
The clones chosen to measure the effect of the mutations in the genes expression were (for 
more information see table S1): 18YFP (focA srlR), 22YFP (dcuB), 25YFP (yjjP/yjjQ radA insX-
insA), 29CFP (arcA) and the ancestral strain of the first colonization. For both aerobic and 
anaerobic conditions we had three biologic replicates from each clone.  
Growth Conditions 
 Aerobic Conditions 
After one overnight growth (24h) in MM with glycerol (0.02%) the cultures were diluted (100-
fold) and then were grown at 37ºC with aeration, in 10ml of M9 minimal medium (MM) 
supplemented with a mixture of the five carbon sources (sorbitol, ribose, mannose, gluconate 
and glucuronate 0.01% from each). At the exponential phase (OD600~0.5) we centrifuged 5ml of 
the bacterial culture at 4ºC during 5minutes at the maximum speed and we discarded the 
supernatant to prevent its growth. After we added lysozyme solution to disrupt the cells wall 
(5mg lysozyme/ml DEPC treated water, sigma protocol) and we incubated the samples at 37ºC 
for 30minutes this process will allow the RNA extraction. 
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 Anaerobic conditions 
After one overnight growth (24h) in MM with glycerol (0.02%) the cultures were diluted (100-
fold) and then were grown at 37ºC in the anaerobic chamber with the atmosphere of 5% H2, 
15% CO2, 80% N2 (Plas Labs, Lansing, MI, USA), in 10ml of M9 minimal medium (MM) 
supplemented with a mixture of the five carbon sources (sorbitol, ribose, mannose, gluconate 
and glucuronate 0.01% from each). At the exponential phase (OD600~0.2) we positioned the 
culture tubes in dry ice to prevent its growth. After we centrifuged 5ml of the bacterial culture at 
4ºC during 5minutes at the maximum speed and we discarded the supernatant.  Next we added 
lysozyme solution to disrupt the cells wall (5mg lysozyme/ml DEPC treated water, sigma 
protocol) and we incubated the samples at 37ºC for 30minutes this process will allow the RNA 
extraction. 
 
RNA extraction, DNAse treatment, RT-PCR and qPCR 
The RNA extraction was performed with the Quiagen RNeasy Mini Kit. RNA concentration 
and quality were evaluated with Nanodrop 2000. DNase treatment was performed with the RQ1 
DNase (Promega), 0.5ul of DNase and 1ul buffer were added to 1ug of RNA and incubated for 
30 minutes at 37ºC. After this, 1ul stop solution was added and then incubated for 15 minutes at 
65ºC to inactivate the DNase. The resulting RNA was used for the reverse transcription which 
consisted in mixing with 1ug of RNA, with 0.5ul random primers and DEPC-water (final volume 
of 15ul) and then incubate at 70ºC for 5min. Afterwards the M-MLV Reverse Transcriptase 
Protocol (Promega) were performed, to the first mix were added 5ul of RTbuffer, 0.5ul RT 
enzyme and 2ul dNTPmix, and then incubated 10min at 25ºC, 50min at 50ºC and 10 min at 
70ºC. 
We used a relative quantification method of analysis with normalization against a reference 
gene.  qPCR was executed in BioRad CFX 384 with itaqSupermix. cDNA was diluted 100-fold 
before used in the qPCR. The qPCR reaction conditions were as follows: one cycle of 2 min at 
50ºC and then 39cycles of 10 min at 95ºC, 30 sec at 95ºC, 1min at 57ºC and finally 30 s at 
72ºC, primers used are listed in table S7. Melt curve analysis was performed to verify product 
homogeneity. All reactions included three replicates for each sample. Data were normalized by 
the Pfaffl method (92) using the hfq housekeeping gene of E.coli as a reference.  
 
 
Statistical analysis: the data presented in this section represent the means of three 
experiments ± standard errors of the mean (SEM). The unpaired (two-sample equal variance 
with two-tailed distribution) t test was used to determine the significance of the differences in the 
gene expression between mutant and ancestral strain, with a significance defined as P value of 
<0.05. 
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Table S1 – Mutations identified in the genomes of the ancestral strains of the first 
colonization (53). Mutations in intergenic regions have the two flanking genes listed (e.g., 
fdrA/ylbF). Genes within brackets mean that the mutation happened within the gene. 
SNPs are represented by an arrow between the ancestral and the evolved nucleotide. 
Whenever a SNP gives rise to a non-synonymous mutation the amino acid replacement is 
also indicated. The symbol Δ means a deletion event and a + symbol represents an 
insertion of the nucleotide that follows the symbol. For intergenic mutations, the numbers 
in the annotation row represent nucleotides relative to each of the neighboring genes, 
where + indicates the distance downstream of the stop codon of a gene and - indicates 
the distance upstream of the gene, that is relative to the start codon. The mutations 
present in the 0YFP but not in the 0CFP, are underlined.  
Clone
Genome 
Position
Gene Mutation Annotation
0YFP 547694 fdrA/ylbF A→G intergenic (+123/‑1156)
547835 fdrA/ylbF +G intergenic (+264/‑1015)
1395405 [ynaJ]–[ttcA] Δ13,756 bp multigenic
1976527 insB–insA Δ776 bp
2369558 arnT 4 bp x 2 duplication
3422257 rrlD A→C noncoding
3422258 rrlD T→A noncoding
3422259 rrlD C→T noncoding
3434719 trkA G→A E60E GAG→GAA
3472447 rpsL T→C K43R AAA→AGA
3844290 uhpT A→C F301V TTT→GTT
3957957 ppiC/rep C→T intergenic (‑121/‑743)
4095684 rhaB/rhaS T→C intergenic (‑213/‑75)
360473 lacA–lacI Δ6264 bp multigenic
788169 [galK] Δ1034 bp
4294082 RIP321 Δ338 bp
Supplements 
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Clone
Genome 
Position
Gene Mutation Annotation
Inferred 
mutations
2173589 gatZ IS Ins coding (755/1263)
4346888 dcuB/dcuR IS Ins intergenic (-121/+450)
2173759 gatZ IS Ins coding (585/1263)
4346888 dcuB/dcuR IS Ins intergenic (‑121/+450)
2560011 yffN G→A C122Y TGC→TAC
2175242 gatY/fbaB IS Ins intergenic (‑16/+292)
4601260 yjjP/yjjQ IS Ins intergenic (‑379/‑244)
4YFP 2173531 gatZ IS1 Ins coding (813/1263) 1
2827493 srlR G→C G142A GGC→GCC
2172869 gatA IS Ins coding (203/453)
2172262 gatC del 1 bp coding (39/1356)
4346888 dcuB/dcuR IS Ins intergenic (‑121/+450)
1420379 ydaV C→A L125M CTG→ATG
1902231 [manZ]–[kdgR] Δ5,451 bp
2175298 gatY/fbaB IS Ins intergenic (-72/+236)
953904 focA/ycaO IS Ins intergenic (-212/+194)
3268729 garK A→G F355S TTC→TCC
2172869 gatA IS Ins coding (203/453)
2827073 srlR A→T K2I AAA→ATA
2172636 gatA IS Ins coding (436/453)
2174223 gatZ Δ2 bp coding (120‑121/1263)
1388754 [ycjY-ynaI] Δ5315 bp large deletion
953904 focA/ycaO IS5 Ins intergenic (-212/+194)
2827095 srlR Δ1 bp coding (27/774)
2172869 gatA IS Ins coding (203/453)
2172079 gatC +C coding (222/1356)
4500113 [insG-yaaI] 2x 151716 bp large duplication
4637714 arcA G→T R206S CGC→AGC
2171153 gatC IS Ins coding (1148/1356)
943941 dmsC G→A W229* TGG→TAG
2175263 gatY/fbaB IS Ins intergenic (-37/+271)
2827117 srlR C→T Q17* CAG→TAG
6YFP
5YFP
3
2
2
3
2
2
2
4
1CFP
2YFP
3YFP
9YFP
8YFP
7YFP
First Step of Adaptation to the mouse gut
14CFP
13CFP
12YFP
11CFP
10CFP
2
2
3
2
2
 
 
 
 
 
 
 
 
 
 
 
 
Table S2.1 -Number and nature of adaptive events across independently evolved clones from the 
first colonization to the mouse gut (53). In the list of mutations, the initials IS denote the 
abbreviation of insertion sequence element at the indicated position. The asterisk means that the 
corresponding SNP originated a STOP codon. For further details see Table S1 legend. The last 
column shows the number of mutations segregating in each sequenced clone. Clone 12YFP was 
the ancestral strain to the second colonization. Mutation yjjY/yjjD is in the arcA regulatory region. 
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Clone
Genome 
Position
Gene Mutation Annotation
Inferred 
mutations
 =17531 nhaA coding (43/1167 nt)
4500113 noncoding (1426/1426 nt) IS4
17YFP 4638771 yjjY/yjtD IS5 (–) +4 bp intergenic (+206/‑191) 1
953901 focA/ycaO IS5 (+) +4 bp intergenic (‑212/+191)
2827229 srlR G→A G54D (GGC→GAC) 
317172 ykgB IS2 (–) +5 bp coding (368‑372/594 nt)
2556721 intZ–[eutA] Δ6,790 bp
20CFP 4347121 dcuB/dcuR A→T intergenic (‑354/+217) 1
4601066 yjjP/yjjQ IS2 (–) +5 bp intergenic (‑185/‑430)
4638684 yjjY/yjtD +TTAT intergenic (+119/‑281)
22YFP 4347105 dcuB/dcuR IS2 (–) +5 bp intergenic (‑338/+229) 1
3174801 cpdA G→A Q19* (CAA→TAA) 
4638719 yjjY/yjtD C→A intergenic (+154/‑246)
24YFP 4625061 radA IS1 (–) +9 bp coding (1127‑1135/1383 nt) 1
279155 insX–insA Δ11,471 bp between IS1
4600992 yjjP/yjjQ IS1 (–) +9 bp intergenic (‑111/‑500)
4625061 radA IS1 (–) +9 bp coding (1127‑1135/1383 nt)
1859452 ydjL/yeaC G→T intergenic (‑96/+274)
4346885 dcuB/dcuR IS5 (–) +4 bp intergenic (‑118/+450)
1301748 oppB IS5 (–) +4 bp coding (826‑829/921 nt)
2827045 gutM/srlR A→T intergenic (+43/‑24)
1301338 oppB IS186 (+) +6 bp :: Δ1 coding (416‑421/921 nt)
2827745 srlR +T coding (677/774 nt)
3805903 rfaQ IS1 (–) +9 bp coding (211‑219/1035 nt)
29CFP 4638628 yjjY/yjtD IS2 (–) +5 bp intergenic (+63/‑333) 1
9531240 focA/ycaO IS1(-)+9bp intergenic (‑174/+224)
4031240 trkH G→A G275R GGG→AGG
21YFP
19CFP
3
18YFP
16YFP
30YFP
28YFP
27CFP
26YFP
25YFP
23CFP
Second Step of Adaptation to the mouse gut
Duplication between 
4500113 and 17531
2
2
2
2
2
2
2
3
2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2.2 -Number and nature of adaptive events across independently evolved clones from 
the second colonization to the mouse gut. 
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Table S3 - Frequencies of newly generated mutations along 432 generations of evolution of 
population 2.7 inside the mouse gut. Clone 12 YFP (see table S2) was the ancestral of the 
second colonization. Yellow and blue shading identify haplotypes belonging to the two sub-
populations of bacteria labeled either with cfp or yfp alleles, the ones with no shading are the 
mutations whose background and haplotype was not possible to estimate. The ancestral 
haplotype is, by definition, devoid of mutations. The genome position for a given mutation is 
only indicated for mutations that are not IS insertions. Mutations in intergenic regions have the 
two flanking genes listed (e.g., dcuB/dcuR). The symbol Δ means a deletion event and a + 
symbol represents an insertion of the nucleotide that follows the symbol. IS insertions at given 
position are indicated as IS Ins. See Figure 4 for a graphical representation of the data in this 
table. 
 
Table S4 - Frequencies of newly generated haplotypes along 432 generations of evolution of 
population 2.14 inside the mouse gut. See Table S3 for further details.  
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Table S5 - Frequencies of newly generated haplotypes along 432 generations of evolution of 
population 2.10 inside the mouse gut. See Table S3 for further details.  
 
 
Table S6 –Oligonucleotide primers used in PCR. 
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Table S7 – Oligonucleotide primers used in qPCR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1 – Emergence and spread of beneficial mutations in the gat operon. Dynamics of 
frequency change of the gat-negative phenotype over time for all populations from the first 
colonization (1.1 to 1.5). For more information see Barroso-Batista et al 2014 (5). 
